Polar Capital Holdings’s Ascendis Pharma A/S ASND Stock Holding History

Polar Capital Holdings’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$165M	Sell	616,908 -34,804	-5%	-$8.13M	0.39%	60
2026 Q1	$149M	Buy	651,712 +281,239	+76%	+$63M	0.53%	48
2025 Q4	$79M	Sell	370,473 -487,438	-57%	-$101M	0.31%	76
2025 Q3	$171M	Buy	857,911 +20,134	+2%	+$3.76M	0.82%	33
2025 Q2	$145M	Buy	837,777 +312,777	+60%	+$50.9M	0.76%	40
2025 Q1	$81.8M	Buy	525,000 +225,000	+75%	+$32.1M	0.5%	55
2024 Q4	$41.3M	Buy	300,000 +75,000	+33%	+$9.86M	0.23%	110
2024 Q3	$33.6M	Buy	+225,000	New	+$30.4M	0.16%	112
2021 Q2	–	Sell	-2,524	Closed	-$325K	–	355
2021 Q1	$325K	Sell	2,524 -50,000	-95%	-$7.6M	﹤0.01%	314
2020 Q4	$8.76M	Buy	+52,524	New	+$8.69M	0.05%	219

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Polar Capital Holdings's ASND Position: Q2 2026 in Review

Polar Capital Holdings reduced its Ascendis Pharma A/S (ASND) stake by 5.3% in Q2 2026, selling an estimated $8.13M and leaving 616,908 shares worth $165M. The position accounts for 0.39% of the portfolio, ranked #60.

Polar Capital Holdings first reported a position in ASND in Q4 2020 and has held it in 10 quarters since. The position peaked at $171M in Q3 2025. 312 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Polar Capital Holdings held 616,908 shares of Ascendis Pharma A/S worth $165M as of Q2 2026.
Polar Capital Holdings sold 34,804 Ascendis Pharma A/S shares in Q2 2026, an estimated $8.13M.
Ascendis Pharma A/S made up 0.39% of Polar Capital Holdings's portfolio in Q2 2026, its #60 holding.
Polar Capital Holdings first reported a position in Ascendis Pharma A/S in Q4 2020 and has held it in 10 quarters since.
Polar Capital Holdings's Ascendis Pharma A/S position peaked at $171M in Q3 2025.
312 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Polar Capital Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.